Quadrature Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.73M | Buy |
+17,982
| New | +$2.73M | 0.05% | 248 |
|
|
2025
Q1 | – | Sell |
-10,215
| Closed | -$1.88M | – | 1132 |
|
|
2024
Q4 | $1.88M | Buy |
10,215
+6,745
| +194% | +$1.24M | 0.04% | 316 |
|
|
2024
Q3 | $683K | Sell |
3,470
-41,941
| -92% | -$8.26M | 0.02% | 435 |
|
|
2024
Q2 | $9.38M | Buy |
45,411
+38,960
| +604% | +$8.05M | 0.16% | 127 |
|
|
2024
Q1 | $1.75M | Buy |
+6,451
| New | +$1.75M | 0.03% | 332 |
|
|
2022
Q4 | – | Sell |
-48,638
| Closed | -$9.59M | – | 893 |
|
|
2022
Q3 | $9.59M | Buy |
48,638
+1,924
| +4% | +$379K | 0.31% | 88 |
|
|
2022
Q2 | $10M | Buy |
46,714
+36,024
| +337% | +$7.71M | 0.42% | 66 |
|
|
2022
Q1 | $3.04M | Buy |
+10,690
| New | +$3.04M | 0.12% | 144 |
|
|
2021
Q1 | – | Sell |
-900
| Closed | -$225K | – | 912 |
|
|
2020
Q4 | $225K | Buy |
+900
| New | +$225K | 0.01% | 687 |
|
|
2020
Q3 | – | Sell |
-3,700
| Closed | -$645K | – | 765 |
|
|
2020
Q2 | $645K | Buy |
+3,700
| New | +$645K | 0.07% | 332 |
|
|
2017
Q2 | – | Sell |
-8,553
| Closed | -$770K | – | 591 |
|
|
2017
Q1 | $770K | Sell |
8,553
-3,585
| -30% | -$323K | 0.06% | 331 |
|
|
2016
Q4 | $925K | Buy |
+12,138
| New | +$925K | 0.06% | 303 |
|